129 related articles for article (PubMed ID: 16954520)
1. High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults.
Baldus CD; Burmeister T; Martus P; Schwartz S; Gökbuget N; Bloomfield CD; Hoelzer D; Thiel E; Hofmann WK
J Clin Oncol; 2006 Oct; 24(29):4714-20. PubMed ID: 16954520
[TBL] [Abstract][Full Text] [Related]
2. Thymic adult T-cell acute lymphoblastic leukemia stratified in standard- and high-risk group by aberrant HOX11L2 expression: experience of the German multicenter ALL study group.
Baak U; Gökbuget N; Orawa H; Schwartz S; Hoelzer D; Thiel E; Burmeister T;
Leukemia; 2008 Jun; 22(6):1154-60. PubMed ID: 18368072
[TBL] [Abstract][Full Text] [Related]
3. Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome.
Baldus CD; Martus P; Burmeister T; Schwartz S; Gökbuget N; Bloomfield CD; Hoelzer D; Thiel E; Hofmann WK
J Clin Oncol; 2007 Aug; 25(24):3739-45. PubMed ID: 17646667
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study.
Marcucci G; Baldus CD; Ruppert AS; Radmacher MD; Mrózek K; Whitman SP; Kolitz JE; Edwards CG; Vardiman JW; Powell BL; Baer MR; Moore JO; Perrotti D; Caligiuri MA; Carroll AJ; Larson RA; de la Chapelle A; Bloomfield CD
J Clin Oncol; 2005 Dec; 23(36):9234-42. PubMed ID: 16275934
[TBL] [Abstract][Full Text] [Related]
5. High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.
Marcucci G; Maharry K; Whitman SP; Vukosavljevic T; Paschka P; Langer C; Mrózek K; Baldus CD; Carroll AJ; Powell BL; Kolitz JE; Larson RA; Bloomfield CD;
J Clin Oncol; 2007 Aug; 25(22):3337-43. PubMed ID: 17577018
[TBL] [Abstract][Full Text] [Related]
6. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
7. High expression of the Ets-related gene (ERG) is an independent prognostic marker for relapse-free survival in patients with acute promyelocytic leukemia.
Hecht A; Nowak D; Nowak V; Hanfstein B; Faldum A; Büchner T; Spiekermann K; Sauerland C; Lengfelder E; Hofmann WK; Nolte F
Ann Hematol; 2013 Apr; 92(4):443-9. PubMed ID: 23250622
[TBL] [Abstract][Full Text] [Related]
8. BAALC and ERG expression in acute myeloid leukemia with normal karyotype: impact on prognosis.
Eid MA; Attia M; Abdou S; El-Shazly SF; Elahwal L; Farrag W; Mahmoud L
Int J Lab Hematol; 2010 Apr; 32(2):197-205. PubMed ID: 19555438
[TBL] [Abstract][Full Text] [Related]
9. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
[TBL] [Abstract][Full Text] [Related]
10. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
Ferrando AA; Neuberg DS; Dodge RK; Paietta E; Larson RA; Wiernik PH; Rowe JM; Caligiuri MA; Bloomfield CD; Look AT
Lancet; 2004 Feb; 363(9408):535-6. PubMed ID: 14975618
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences.
van Grotel M; Meijerink JP; van Wering ER; Langerak AW; Beverloo HB; Buijs-Gladdines JG; Burger NB; Passier M; van Lieshout EM; Kamps WA; Veerman AJ; van Noesel MM; Pieters R
Leukemia; 2008 Jan; 22(1):124-31. PubMed ID: 17928886
[TBL] [Abstract][Full Text] [Related]
12. t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH).
Berger R; Dastugue N; Busson M; Van Den Akker J; Pérot C; Ballerini P; Hagemeijer A; Michaux L; Charrin C; Pages MP; Mugneret F; Andrieux J; Talmant P; Hélias C; Mauvieux L; Lafage-Pochitaloff M; Mozziconacci MJ; Cornillet-Lefebvre P; Radford I; Asnafi V; Bilhou-Nabera C; Nguyen Khac F; Léonard C; Speleman F; Poppe B; Bastard C; Taviaux S; Quilichini B; Herens C; Grégoire MJ; Cavé H; Bernard OA;
Leukemia; 2003 Sep; 17(9):1851-7. PubMed ID: 12970786
[TBL] [Abstract][Full Text] [Related]
13. Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children's Cancer Group (CCG).
Kees UR; Heerema NA; Kumar R; Watt PM; Baker DL; La MK; Uckun FM; Sather HN
Leukemia; 2003 May; 17(5):887-93. PubMed ID: 12750702
[TBL] [Abstract][Full Text] [Related]
14. The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols.
van Grotel M; Meijerink JP; Beverloo HB; Langerak AW; Buys-Gladdines JG; Schneider P; Poulsen TS; den Boer ML; Horstmann M; Kamps WA; Veerman AJ; van Wering ER; van Noesel MM; Pieters R
Haematologica; 2006 Sep; 91(9):1212-21. PubMed ID: 16956820
[TBL] [Abstract][Full Text] [Related]
15. Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.
Ben Abdelali R; Asnafi V; Leguay T; Boissel N; Buzyn A; Chevallier P; Thomas X; Lepretre S; Huguet F; Vey N; Escoffre-Barbe M; Tavernier E; Reman O; Fegueux N; Turlure P; Rousselot P; Cahn JY; Lheritier V; Chalandon Y; Béné MC; Macintyre E; Dombret H; Ifrah N;
Blood; 2011 Nov; 118(19):5099-107. PubMed ID: 21835957
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of CD13 identifies a subgroup of standard-risk adult acute lymphoblastic leukemia with inferior survival.
Dalal BI; Al Mugairi A; Pi S; Lee SY; Khare NS; Pal J; Bryant A; Vakil AP; Lau S; Abou Mourad YR
Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):239-44. PubMed ID: 24411984
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
[TBL] [Abstract][Full Text] [Related]
18. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis.
Ballerini P; Blaise A; Busson-Le Coniat M; Su XY; Zucman-Rossi J; Adam M; van den Akker J; Perot C; Pellegrino B; Landman-Parker J; Douay L; Berger R; Bernard OA
Blood; 2002 Aug; 100(3):991-7. PubMed ID: 12130513
[TBL] [Abstract][Full Text] [Related]
19. Two dual-color split signal fluorescence in situ hybridization assays to detect t(5;14) involving HOX11L2 or CSX in T-cell acute lymphoblastic leukemia.
van Zutven LJ; Velthuizen SC; Wolvers-Tettero IL; van Dongen JJ; Poulsen TS; MacLeod RA; Beverloo HB; Langerak AW
Haematologica; 2004 Jun; 89(6):671-8. PubMed ID: 15194534
[TBL] [Abstract][Full Text] [Related]
20. High incidence of Hox11L2 expression in children with T-ALL.
Mauvieux L; Leymarie V; Helias C; Perrusson N; Falkenrodt A; Lioure B; Lutz P; Lessard M
Leukemia; 2002 Dec; 16(12):2417-22. PubMed ID: 12454747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
